Paper41675331
Mechanistic insights into hepatic metastasis of pancreatic cancer: molecular perspectives.
Yang H and 4 others. Transl Gastroenterol Hepatol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Mechanistic insights into hepatic metastasis of pancreatic cancer: molecular perspectives. Papers, record 41675331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41675331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanistic insights into hepatic metastasis of pancreatic cancer: molecular perspectives.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References123
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29983708 | Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis. | Gastroenterol Res Pract | 2018 | https://conductscience.org/library/papers/29983708 | PubMed |
| 2 | 38343537 | Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2. | Front Immunol | 2024 | https://conductscience.org/library/papers/38343537 | PubMed |
| 3 | 36634919 | Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model. | J Immunother Cancer | 2023 | https://conductscience.org/library/papers/36634919 | PubMed |
| 4 | 37463056 | Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer. | Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37463056 | PubMed |
| 5 | 31133044 | Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31133044 | PubMed |
| 6 | 37370109 | Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37370109 | PubMed |
| 7 | 37210549 | The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37210549 | PubMed |
| 8 | 39690180 | ITGA3 promotes pancreatic cancer progression through HIF1α- and c-Myc-driven glycolysis in a collagen I-dependent autocrine manner. | Cancer Gene Ther | 2025 | https://conductscience.org/library/papers/39690180 | PubMed |
| 9 | 35775964 | Facts and Hopes in Immunotherapy of Pancreatic Cancer. | Clin Cancer Res | 2022 | https://conductscience.org/library/papers/35775964 | PubMed |
| 10 | 32398667 | Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32398667 | PubMed |
| 11 | 39709178 | Tumor-derived exosomes: Unravelling the pathogenesis of pancreatic cancer with liver metastases and exploring the potential for clinical translation. | Cancer Lett | 2025 | https://conductscience.org/library/papers/39709178 | PubMed |
| 12 | 37291757 | Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression. | J Pathol Clin Res | 2023 | https://conductscience.org/library/papers/37291757 | PubMed |
| 13 | 33941611 | TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer. | Cancer Res | 2021 | https://conductscience.org/library/papers/33941611 | PubMed |
| 14 | 30042387 | MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/30042387 | PubMed |
| 15 | 31954769 | The CCR5 antagonist maraviroc causes remission of pancreatic cancer liver metastasis in nude rats based on cell cycle inhibition and apoptosis induction. | Cancer Lett | 2020 | https://conductscience.org/library/papers/31954769 | PubMed |
| 16 | 36827980 | NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36827980 | PubMed |
| 17 | 38280684 | Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma. | Gastroenterology | 2024 | https://conductscience.org/library/papers/38280684 | PubMed |
| 18 | 40098997 | Inhibition of CD53 Reduces the Formation of ROS-Induced Neutrophil Extracellular Traps and Protects Against Inflammatory Injury in Acute Pancreatitis. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/40098997 | PubMed |
| 19 | 32934728 | MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways. | Oncol Lett | 2020 | https://conductscience.org/library/papers/32934728 | PubMed |
| 20 | 33852841 | Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer. | Cell Rep | 2021 | https://conductscience.org/library/papers/33852841 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 | NCBI Gene |
| IGF1R | 3480 | PubTator's text mining | https://conductscience.org/library/genes/3480 | NCBI Gene |
| PAK2 | 5062 | PubTator's text mining | https://conductscience.org/library/genes/5062 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| PIK3R1 | 5295 | PubTator's text mining | https://conductscience.org/library/genes/5295 | NCBI Gene |
| PTK2B | 2185 | PubTator's text mining | https://conductscience.org/library/genes/2185 | NCBI Gene |
| SNAI2 | 6591 | PubTator's text mining | https://conductscience.org/library/genes/6591 | NCBI Gene |
| SOX2 | 6657 | PubTator's text mining | https://conductscience.org/library/genes/6657 | NCBI Gene |
| TAFAZZIN | 6901 | PubTator's text mining | https://conductscience.org/library/genes/6901 | NCBI Gene |
| YAP1 | 10413 | PubTator's text mining | https://conductscience.org/library/genes/10413 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41675331
GET https://conductscience.org/api/papers/v1/41675331/references?page=2